SCHEMBL8897871

SCHEMBL8897871

CCC=CCCC(CC)c1cc2ccccc2c(C(N)=O)c1CC

nearest known ligand 0.34

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
GAA P10253 1/20 0.34
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
GLA P06280 1/20 0.31
HPGD P15428 1/20 0.31
CYP2C19 P33261 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD17B10 Q99714 1/20 0.31
PLA2G1B P04054 1/20 0.31
TACR3 P29371 1/20 0.30
EPHX2 P34913 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8897205 0.91 KDM4E (0.32) KDM4EALDH1A1GAAMEN1CYP1A2
SCHEMBL8898755 0.85 TACR3 (0.31) KDM4EALDH1A1MEN1CYP1A2GLA
SCHEMBL8897899 0.84 CNR2 (0.36) KDM4EALDH1A1MEN1CYP1A2GLA
SCHEMBL8897858 0.83 ALDH1A1 (0.35) KDM4EALDH1A1GAAMEN1CYP1A2
SCHEMBL8901090 0.83 PLA2G1B (0.32) KDM4EALDH1A1MEN1CYP1A2GLA
SCHEMBL8896422 0.76 PARP1 (0.35) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL8895630 0.75 NCEH1 (0.34) KDM4EALDH1A1GAACYP1A2CYP2C19
SCHEMBL8897200 0.75 ALDH1A1 (0.32) KDM4EALDH1A1GAAMEN1CYP1A2
SCHEMBL15090920 0.71 ALDH1A1 (0.44) KDM4EALDH1A1GAAMEN1CYP1A2
SCHEMBL8898691 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5703091-A N-substituted azabicycloalkane derivatives, their preparation and use BASF AKTIENGESELLSCHAFT (DE) 1997-12-30 US disclosed
EP-0731802-A1 N-SUBSTITUTED AZABICYCLOALKANE DERIVATIVES AS NEUROLEPTIKA ASF BASF AKTIENGESELLSCHAFT (DE) 1996-09-18 EP disclosed
WO-1995015327-A1 N-SUBSTITUTED AZABICYCLOALKANE DERIVATIVES AS NEUROLEPTIKA ASF BASF AKTIENGESELLSCHAFT (DE) 1995-06-08 WO disclosed